CLINICAL_TRIALS
trial_result
· 2014-10-28
Clinical Trial Update: Treatment of Relapsed Promyelocytic Leukemia With Arsenic Trioxide (ATO) [Phase 4]
Summary
A Phase 4 clinical trial evaluating arsenic trioxide for relapsed acute promyelocytic leukemia has been completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: PETHEMA Foundation | Conditions: Acute Promyelocytic Leukemia | Phase 4 | Status: COMPLETED